The IPBS (Institute of Pharmacology and Structural Biology) is seeking motivated PhD candidates as part of the BEST Doctoral Programme of the University of Toulouse.
Located in Toulouse, in the sunny southwestern of France, IPBS is a leading research institute affiliated with the National Center for Scientific Research (CNRS) – the largest public research organization in France – and the University of Toulouse.
IPBS conducts state-of the-art research in cancer biology, immunology, microbiology, structural biology and biophysics. It is a world leader in the discovery, characterization, validation and exploitation of novel pathways and pharmacological targets in the fields of cancer, infection, and inflammation. The institue combines molecular and cellular biology approaches and in vivo experiments.
These PhD opportunities are offered through the BEST Doctoral Programme, led by the University of Toulouse and co-funded by the European Union through Horizon Europe – Marie Skłodowska-Curie Actions (MSCA COFUND) and the Toulouse Initiative for Research’s Impact on Society (TIRIS).
Thanks to this programme, 19 doctoral candidates will be recruited this year through an international co-supervision scheme across three major TIRIS thematic pillars (Health & Well-being, Global Changes and Sustainable Transitions).
The entire recruitment process will be managed by the University of Toulouse (UT). For additional information : https://doctorat.univ-toulouse.fr/cofund-best
At IPBS, we are offering 5 PhD opportunities.
| Thesis project Click on a project to view the full project description. | Supervisor Host Institution | Co-supervisor Co-supervising institution |
| RNA Polymerase II Citrullination as a Regulator of Transcriptional Control in Triple-Negative Breast Cancer | Priyanka Sharma – IPBS, CNRS-UT, France | Dr. Juan Torreño Piña – National Center for Biotechnology, CSIC, Madrid, Spain |
| Understanding and Engineering the Cellular Properties of G-Quadruplex Ligands | Dennis Gomez – IPBS, CNRS, UT, France | Dr. Anne Petitjean – Queen’s University, Ontario, Canada |
| REMEDY-HIV : REprogramming Host MEmbrane dYnamics for Anti-HIV Therapy | Fabrice Dumas – IPBS, CNRS, UT, France | Dr. Luciana Balboa – Instituto de Medicina Experimental (IMEX)-CONICET, Academia Nacional de Medicina, Buenos Aires C1425ASU, Argentina |
| MAP-GET : Mapping of cellular targets following gene electrotransfer in tumors | Muriel Golzio – IPBS, CNRS-UT, France | Dr. Bostjan Markelc – Institute of Oncology, Ljubljana, Slovenia |
| Mechanics of tumor cell trogocytosis by macrophages | Renaud Poincloux – IPBS, CNRS-UT France | pencer Freeman, University of Toronto, Canada |
Call for application – 23 November 2026
Applications must be submitted online through the application platform : edd-projets.utoulouse.fr
Please contact us at international@ipbs.fr for any questions regarding IPBS and/or the recruitment process.
Eligibility check – 24 to 30 November 2026
Written evaluation – 4 December to 15 January 2027
Consolidation of pre-selected projects – 19 January to 19 March 2027
Oral evaluation – 29 March to 4 April 2027
Result – April 2027
Starting date: September/October 2027 (Contract duration: 36 months)
For additional information: https://doctorat.univ-toulouse.fr/cofund-best
Contact : best-helpdesk@utoulouse.fr
We offer :
Toulouse offers a dynamic and affordable city with rich culture, and a high quality of life.
Situated between the Mediterranean and the Atlantic, close to the Pyrenees’ Mountain, Toulouse has long been a major crossroad in Europe. Attracting 15,000 newcomers every year, Toulouse boasts a particularly rich vibrant cultural and artistic heritage. Capital of Occitanie Region, the leading French region for research and innovation – with over 15,000 academic researchers and 7,500 PhD students, R&D represents 3.5% of its GDP in 2022.
